Class 564/95 - Substituent Q is acyclic

Subclass of Class 564 - Organic compounds -- part of the class 532-570 series
Definition: Compounds wherein the sulfonic acid residue contains no
No. of patents: 115
Last issue date: 05/20/2008

«First «Previous1 2 3 Next»Last»

Number	Title	Issue Date
7375120	Peptide deformylase inhibitors Novel PDF inhibitors and novel methods for their use are provided. ...	05/20/2008
7365196	Sulphonamido-substituted bridged bicycloalkyl derivatives A class of compounds is disclosed, comprising sulphonamido-substituted bridged bicycloalkyl structures. The compounds are inhibitors of gamma-secretase, and hence are useful in the treatment of and/or prevention of Alzheimer's disease. ...	04/29/2008
7338958	Sulfoximine-substituted pyrimidines as CDK-and/or VEGF inhibitors, their production and use as pharmaceutical agents This invention relates to pyrimidine derivatives of general formula I in which Q, R1, R2, R3, R4, R5, X, and m have the meanings that are contained in the description, ...	03/04/2008
7321063	Sulfonamide inhibitors of aspartyl protease The present invention relates to a novel class of sulfonamides which are aspartyl protease inhibitors. In one embodiment, this invention relates to a novel class of HIV aspartyl protease inhibitors characterized by specific structural and physicochemical features. T...	01/22/2008
7253317	Method for fluorinating a compound comprising a halosulphonyl or dihalophosphonyl group The invention relates to a fluorination process for producing fluorinated compounds. The process consists in reacting a compound (I) corresponding to the formula with an ionic fluoride of a monovalent cati...	08/07/2007
7217492	Onium salt compound and radiation-sensitive resin composition An onium salt compound having a cation moiety of the following formula (1) is disclosed. wherein A represents I or S, m is 1 or 2, n is 0 or 1, x is 1–10, and Ar1 and Ar2 are (substituted) aromatic hydrocarbon ...	05/15/2007
7196119	Development of new selective estrogen receptor modulators The present disclosure concerns a new class of selective estrogen receptor modulators (SERMs). The disclosure also includes the identification of a previously unknown membrane associated estrogen receptor. Methods for making and using the disclosed SERMs are disclos...	03/27/2007
7169952	Process to prepare sulfonamides A process for the preparation of a sulfonamide of formula (II), comprising reacting at elevated temperature an aniline of formula (I), with a sulfonating agent A of the formula R1—SO2-Z in the presence of a catalytic amount of either: (i) an ...	01/30/2007
6958416	Valproyltaurinamide derivatives as anticonvulsant amd CNS active agents The invention relates to derivatives of valproyltaurinamide of formula (I) in which R1 and R2 are independently hydrogen, a C1-C6-alkyl group, an arylalkyl group or an aryl group. The derivatives are especially useful for ...	10/25/2005
6908947	Sulfonamide-substituted fused 7-membered ring compounds, their use as a medicament, and pharmaceutical preparations comprising them The present invention relates to compounds of formula I, in which X1, X2, X3, X4, Y1, Y2, Y3, Y4, R(3), R(4) and R(5) have the meanings mentioned in the specification, their preparation and their use, in particular in ...	06/21/2005
6743929	Sulfonylalkanoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors Sulfonamide-containing hydroxyethylamine compounds are effecive as retroviral protease inhibitors, and in particular as inhibitors of HIV protease. ...	06/01/2004
6706765	Aminoguanidines and alkoxyguanidines as protease inhibitors Aminoguanidine and alkoxyguanidine compounds, including compounds of the formula: wherein X is O or NR9 and R1-R4, R6-R9, R11, R12, Ra	03/16/2004
6699904	PPAR agonists PPAR alpha activators, pharmaceutical compositions containing such compounds and the use of such compounds to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-c...	03/02/2004
6635783	Bicyclic 1,3-aminoalcohols, d8-metal complexes and hydrogenation processes Bicyclic amino alcohols, whose amino group and hydroxy group are bonded in positions 1,3 adjacent to the bridge, for example ##STR1## are valuable ligands for metal complexes of the d-8 metals of the periodic table of elements. The metal complexes in ques...	10/21/2003
6620858	Colorants containing copolymerizable vinyl groups and sulfonamide linkages Disclosed are thermally-stable, colored, photopolymerizable compounds containing a vinyl group which are capable of being copolymerized with reactive vinyl monomers to produce colored compositions such as polyacrylates, polymethacrylates, polystyrene, etc...	09/16/2003
6583318	Method for synthesis of ଱-sulfonamido amide, carboxylic acid and hydroxamic acid derivatives A method of synthesizing ଱-sulfonamido amide, carboxylic acid or hydroxamic acid derivatives comprising providing a set of polymer-bound reactant(s) (sulfonamide, aldehyde or ketone, isocyanide or acid) to react with three sets of the other three re...	06/24/2003
6576632	Biaryl compounds useful as anticancer agents The present invention relates to compounds of formula I ##STR1## and to pharmaceutically acceptable salts, hydrates and prodrugs thereof, wherein R1, R2, R3, R4, R5, R10, R11, b,...	06/10/2003
6506733	Compounds and compositions as protease inhibitors Compounds of the formula: ##STR1## are provided, and are useful as cysteine protease inhibitors, particularly in the treatment of diseases such as osteoporosis or autoimmune disorders in which cathepsins K or S contribute to the pathology or symptomatolgy...	01/14/2003
6459003	Ether compounds The present invention relates to novel ether compounds, compositions comprising ether compounds, and methods useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders comprising administer...	10/01/2002
6455502	Compounds and compositions as protease inhibitors The present invention relates to novel N-cyanomethyl amides which are cysteine protease inhibitors, the pharmaceutically acceptable salts and N-oxides thereof, their uses as therapeutic agents and the methods of their making....	09/24/2002
6369073	Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase Compounds of formula (I) ##STR1## wherein the groups are as defined in the description are disclosed. The compounds of formula (I) are endowed with reversible inhibiting activity of carnitine palmitoyl-transferase and are useful in the preparation of medi...	04/09/2002
6333349	Sulfonamide-substituted fused 7-membered ring compounds, their use as a medicament, and pharmaceutical preparations comprising them The present invention relates to compounds of formula I, ##STR1## in which X1, X2, X3, X4, Y1, Y2, Y3, Y4, R(3), R(4) and R(5) have the meanings mentioned in the specification, their preparation and their use, in particular in pharmaceuticals. The compoun...	12/25/2001
6271262	Metalloproteinase inhibitors A compound of formula (I) ##STR1## useful as metalloproteinase inhibitors....	08/07/2001
6271261	IL-8 receptor antagonists Novel IL-8 receptor antagonists and methods of using them are provided....	08/07/2001
6235787	Hydrazine derivatives Hydrazine derivatives of the formula ##STR1## wherein Y is CO or SO2 ; R1 is lower alkyl, lower alkenyl, lower cycloalkyl, lower cycloalkyl-lower alkyl, aryl or aryl-lower alkyl; R2 is lower alkyl, halo-lower alkyl, aryl-l...	05/22/2001
6046236	Carbocyclic sulfonamides (1) Prostaglandin (PG) E2 antagonist or agonist containing carbocyclic sulfonamides represented by the compound of the formula (I): ##STR1## cyclodextrin clathrates thereof, non-toxic salts thereof as active ingredient, (2) carbocyclic sul...	04/04/2000
6034067	Serine protease inhibitors The invention relates to a compound having formula (I), wherein A, B, X, N, Z and Q are defined as described in the description. The compounds of the invention have anticoagulant activity and can be used in treating or preventing thrombin-related diseases...	03/07/2000
5977384	Benzothiazolone derivatives A compound of formula I, including optical isomers thereof, ##STR1## wherein X represents --SO2 NH-- or --NHSO2 --, p, q and r independently represent 2 or 3; Y represents thienyl optionally substituted by alkyl or halogen, or phenyl...	11/02/1999
5965588	Sulfonylalkanoylamino hydroxyethylamimo sulfonamides useful as retroviral protease inhibitors Sulfonamide-containing hydroxyethylamine compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease....	10/12/1999
5948487	Anisotropic retardation layers for display devices A composition that includes the following compounds: ##STR1## wherein R1, which may be the same or different, is a hydrophilic group; R2, which may the same or different, is selected from the group consisting of electron donatin...	09/07/1999
5869725	Derivatives of aminosulfonic acids, utilization of the same in the synthesis of pseudopeptides and process for their preparation Derivatives of gamma-amino-alpha,beta-unsaturated sulfonic acids, a process for the preparation of the same and their utilization in the synthesis of pseudopeptides characterized by the presence of at least a sulfonamide type bond conjugated to a double b...	02/09/1999
5861535	Reductive alkylation process to prepare tertiary aminoaryl compounds Tertiary aminoaryl compounds, such as N,N'dialkylaminoaryl compounds, are prepared using successive reductive steps without isolation therebetween, at high temperature and pressure. A nitroaryl compound is reduced using a ketone as both solvent and reacta...	01/19/1999
5852007	Cysteine and serine protease inhibitors containing D-amino acid at the P2 position, methods of making same, and methods of using same The present invention is directed to (D)-amino acid containing inhibitors of cysteine or serine proteases. Methods for the use of the protease inhibitors are also described....	12/22/1998
5847206	Amphiphilic fluorine derivatives with telomeric structures; preparation procedure and biomedical applications New fluorinated derivatives useful as surfactants or in the transport of drug or markers, or in drug targeting, and preparations containing the derivatives, for medical, cosmetic and veterinary uses, having the formula: ##STR1## wherein RF	12/08/1998
5814110	Chemical compositions and use as fuel additives Distillate fuel is treated with additives whose structure match the crystal planes of the wax which crystallizes from the fuel to produce crystals below 4000 nanometres in size, suitable additive include novel sulpho-carboxylic materials particularly thei...	09/29/1998
5705689	Aza compounds as anion receptors A family of aza-ether based compounds including linear, multi-branched and aza-crown ethers is provided. When added to non-aqueous battery electrolytes, the family of aza-ether based compounds acts as neutral receptors to complex the anion moiety of the e...	01/06/1998
5691366	Nitro compounds, process for preparation thereof and use thereof A new nitro compound of the formula: ##STR1## wherein R1 and R2 are each lower alkyl or lower alkoxy(lower)-alkyl, or ##STR2## is cyclized to form ##STR3## X is --O--, --S-- or --NH--, m is an integer 0 or 1, and...	11/25/1997
5663417	Carbocyclic sulfonamides (1) Prostaglandin (PG) E2 antagonist or agonist containing carbocyclic sulfonamides represented by the compound of the formula (I): ##STR1## cyclodextrin clathrates thereof, non-toxic salts thereof as active ingredient, (2) carbocyclic sul...	09/02/1997
5631394	Pharmaceutically active ceramide-related compounds This invention provides a compound having the formula R1 --Y1 --CHZ1 --CH(NY2 Y3)--CH2 --Z2, wherein: R1 is a straight-chained alkyl, alkenyl or alkynyl group having from 8...	05/20/1997
5621144	Fluorinated compounds as oxygen transport agents New compounds are described typically having the formula CH3 C(CH2 R)3 or ZCH2 C(CH2 R)3 where R is a fluorohydrocarbon or perfluorocarbon group, preferably containing 4-16 carbon atoms and...	04/15/1997

«First «Previous1 2 3 Next»Last»

PatentStorm

Bizarre Patents

PatentStorm News

Class 564/95 - Substituent Q is acyclic